Jacobo Porto Álvarez

Mr. Jacobo Porto Álvarez

Radiology, Complejo Hospitalario Universitario de Santiago, Santiago de Compostela, Galicia, Spain
+1
orcid
Radiologist in Complexo Hospitalario Universitario de Santia...

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 July 2023 in Biomedicines
Verified
Journal Article
Open access
PDF file
JÁJacobo Porto Álvarez
Jacobo Porto Álvarez
Eva CernadasEva Cernadas
Eva Cernadas
RMRebeca Aldaz Martínez
Rebeca Aldaz Martínez
Manuel Fernández-DelgadoManuel Fernández-Delgado
Manuel Fernández-Delgado
EZEmilio Huelga Zapico
Emilio Huelga Zapico
MSMiguel Souto
Miguel Souto
Colorectal cancer (CRC) is one of the most common types of cancer worldwide. The KRAS mutation is present in 30–50% of CRC patients. This mutation confers resistance to treatment with anti-EGFR therapy. This article aims at proving that computer tomography (CT)-based radiomics can predict the KRAS mutation in CRC patients. The piece is a retrospective study with 56 CRC patients from the Hospital of Santiago de Compostela, Spain. All patients had a confirmatory pathological analysis of the KRAS status. Radiomics features were obtained using an abdominal contrast enhancement CT (CECT) before applying any treatments. We used several classifiers, including AdaBoost, neural network, decision tree, support vector machine, and random forest, to predict the presence or absence of KRAS mutation. The most reliable prediction was achieved using the AdaBoost ensemble on clinical patient data, with a kappa and accuracy of 53.7% and 76.8%, respectively. The sensitivity and specificity were 73.3% and 80.8%. Using texture descriptors, the best accuracy and kappa were 73.2% and 46%, respectively, with sensitivity and specificity of 76.7% and 69.2%, also showing a correlation between texture patterns on CT images and KRAS mutation. Radiomics could help manage CRC patients, and in the future, it could have a crucial role in diagnosing CRC patients ahead of invasive methods.

7 September 2020 in Applied Sciences
Verified
Journal Article
Open access
PDF file
Victor Gonzalez CastroVictor Gonzalez Castro
Victor Gonzalez Castro
Eva CernadasEva Cernadas
Eva Cernadas
EHEmilio Huelga
Emilio Huelga
Manuel Fernández-DelgadoManuel Fernández-Delgado
Manuel Fernández-Delgado
JÁJacobo Porto Álvarez
Jacobo Porto Álvarez
MSMiguel Souto
Miguel Souto
In this work, by using descriptive techniques, the characteristics of the texture of the CT (computed tomography) image of patients with colorectal cancer were extracted and, subsequently, classified in KRAS+ or KRAS-. This was accomplished by using different classifiers, such as Support Vector Machine (SVM), Grading Boosting Machine (GBM), Neural Networks (NNET), and Random Forest (RF). Texture analysis can provide a quantitative assessment of tumour heterogeneity by analysing both the distribution and relationship between the pixels in the image. The objective of this research is to demonstrate that CT-based Radiomics can predict the presence of mutation in the KRAS gene in colorectal cancer. This is a retrospective study, with 47 patients from the University Hospital, with a confirmatory pathological analysis of KRAS mutation. The highest accuracy and kappa achieved were 83% and 64.7%, respectively, with a sensitivity of 88.9% and a specificity of 75.0%, achieved by the NNET classifier using the texture feature vectors combining wavelet transform and Haralick coefficients. The fact of being able to identify the genetic expression of a tumour without having to perform either a biopsy or a genetic test is a great advantage, because it prevents invasive procedures that involve complications and may present biases in the sample. As well, it leads towards a more personalized and effective treatment.

9 February 2023 in Applied Sciences
Verified
Journal Article
Open access
PDF file
JÁJacobo Porto Álvarez
Jacobo Porto Álvarez
GBGary T. Barnes
Gary T. Barnes
AMAlex Villanueva Moure
Alex Villanueva Moure
RGRoberto García-Figueiras
Roberto García-Figueiras
SGSandra Baleato Gonzalez
Sandra Baleato Gonzalez
MSMiguel Souto
Miguel Souto
Computed tomography (CT) introduced medicine to digital imaging. This occurred in the early 1970s and it was the start of the digital medical imaging revolution. The resulting changes and improvements in health care associated with digital imaging have been marked, are occurring now, and are likely to continue into the future. Before CT, medical images were acquired, stored, and displayed in analog form (i.e., on film). Now essentially all medical images are acquired and stored digitally. When they are not viewed by computer, they are converted to an analog image to be seen. The application of computer algorithms and the processing of digital medical images improves the visualization of diagnostically important details and aids diagnosis by extracting significant quantitative information. Examples of this can be seen with CAD and radiomics applications in the diagnosis of lung and colorectal cancer, respectively. The objectives of this article are to point out the key aspects of the digital medical imaging revolution, to review its current status, to discuss its clinical translation in two major areas: lung and colorectal cancer, and to provide future directions and challenges of these techniques.

6 September 2023 in Applied Sciences
Verified
Journal Article
Open access
PDF file
JÁJacobo Porto Álvarez
Jacobo Porto Álvarez
AMAntonio Mosqueira Martínez
Antonio Mosqueira Martínez
JFJavier Martínez Fernández
Javier Martínez Fernández
MLMarta Sanmartín López
Marta Sanmartín López
MUMiguel Blanco Ulla
Miguel Blanco Ulla
MSMiguel Souto
Miguel Souto
Acute ischemic stroke (AIS) is the loss of neurological function due to a sudden reduction in cerebral blood flow and is a leading cause of disability and death worldwide. The field of radiological imaging has experienced growth in recent years, which could be boosted by the advent of artificial intelligence. One of the latest innovations in artificial intelligence is radiomics, which is based on the fact that a large amount of quantitative data can be extracted from radiological images, from which patterns can be identified and associated with specific pathologies. Since its inception, radiomics has been particularly associated with the field of oncology and has shown promising results in a wide range of clinical situations. The performance of radiomics in non-tumour pathologies has been increasingly explored in recent years, and the results continue to be promising. The aim of this review is to explore the potential applications of radiomics in AIS patients and to theorize how radiomics may change the paradigm for these patients in the coming years.

12 October 2023 in American Journal of Neuroradiology
Verified
Journal Article
Open access
PDF file
MTMikel Terceño
Mikel Terceño
SBSaima Bashir
Saima Bashir
Josep PuigJosep Puig
Josep Puig
PDPepus Daunis-i-Estadella
Pepus Daunis-i-Estadella
EMEduardo Murias
Eduardo Murias
YSYolanda Silva
Yolanda Silva
BACKGROUND AND PURPOSE: Several nonrandomized studies have demonstrated the effectiveness of balloon guide catheters in treating patients with anterior circulation large-vessel occlusion. However, their impact on the elderly populations has been underreported. We aimed to analyze the effect of balloon guide catheters in a cohort of elderly patients (80 years of age or older) with anterior circulation large-vessel occlusion. MATERIALS AND METHODS: Consecutive patients from June 2019 to June 2022 were collected from the ROSSETTI Registry. Demographic and clinical data, angiographic endovascular technique, and clinical outcome were compared between balloon guide catheter and non-balloon guide catheter groups. We studied the association between balloon guide catheters and the rate of complete recanalization after a single first-pass effect modified TICI 2c–3, as well as their association with functional independence at 3 months. RESULTS: A total of 808 patients were included during this period, 465 (57.5%) of whom were treated with balloon guide catheters. Patients treated with balloon guide catheters were older, had more neurologic severity at admission and lower baseline ASPECTS, and were less likely to receive IV fibrinolytics. No differences were observed in terms of the modified first-pass effect between groups (45.8 versus 39.9%, P = .096). In the multivariable regression analysis, balloon guide catheter use was not independently associated with a modified first-pass effect or the final modified TICI 2c–3, or with functional independence at 3 months. CONCLUSIONS: In our study, balloon guide catheter use during endovascular treatment of anterior circulation large-vessel occlusion in elderly patients did not predict the first-pass effect, near-complete final recanalization, or functional independence at 3 months. Further studies, including randomized clinical trials, are needed to confirm these results.

21 February 2025 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
COCrhistian-Mario Oblitas
Crhistian-Mario Oblitas
ASAna Sampedro-Viana
Ana Sampedro-Viana
SFSabela Fernández-Rodicio
Sabela Fernández-Rodicio
MRManuel Rogríguez-Yáñez
Manuel Rogríguez-Yáñez
ILIria López-Dequidt
Iria López-Dequidt
RIRamón Iglesias-Rey
Ramón Iglesias-Rey
Objective: This study aimed to investigate potential specific molecular and neuroimaging biomarkers for stroke subtype recurrence to improve secondary stroke prevention. Methods: A retrospective analysis was conducted on a prospective stroke biobank. The main endpoint was to evaluate the association between different biomarkers and the recurrence of stroke subtypes. Serum levels of interleukin 6 (IL-6) and tumor necrosis factor-alpha (TNF-a) were analyzed as inflammation biomarkers; N-terminal pro-B-type natriuretic peptide (NT-pro-BNP) and microalbuminuria were used as atrial/endothelial dysfunction biomarkers, while leukoaraiosis (LA) and soluble TNF-like inducers of apoptosis (sTWEAK) were used as biomarkers for blood–brain barrier dysfunction. Demographic and clinical variables were also included. Results: A total of 5038 stroke patients were included, with a mean follow-up of 4.9 years (±3.3). Stroke recurrences were observed in 18.4% of patients (927 individuals). The main results found were as follows: LA was independently associated with lacunar stroke recurrence (adjusted OR 9.50; 95% CI: 3.12–28.93). NT-pro-BNP levels higher than >1000 pg/mL were independently associated with cardioembolic stroke recurrence (adjusted OR 1.80; 95% CI: 1.23–2.61). Persistently elevated TNF-a levels (>24 pg/mL) after stroke recurrence showed an adjusted OR of 21.26 (95% CI: 12.42–37.59) for atherothrombotic subtype, whereas persistently high sTWEAK levels (>7000 pg/mL) after a second hemorrhagic stroke showed an adjusted OR of 4.81 (95% CI: 2.86–8.07) for hemorrhagic subtype. Conclusions: The presence of LA and high levels of NT-pro-BNP, TNF-a, and sTWEAK were associated with an increased risk for lacunar, cardioembolic, atherothrombotic, and hemorrhagic stroke recurrences, respectively.